Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma-Reference-Cited by-同舟云学术

Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma

Published:2024-04 Issue: Volume:193 Page:110121
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Corrigan Kelsey L.^ORCID,Xu Ting,Sasaki Yuki,Lin Ruitao,Chen Aileen B.,Welsh James W.,Lin Steven H.,Chang Joe Y.,Ning Matthew S.^ORCID,Gandhi Saumil,O'Reilly Michael S.,Gay Carl M.,Altan Mehmet^ORCID,Lu Charles,Cascone Tina,Koutroumpakis Efstratios,Sheshadri Ajay^ORCID,Zhang Xiaodong^ORCID,Liao Li,Zhu X. Ronald,Heymach John V.,Nguyen Quynh-Nhu,Liao Zhongxing

Funder

University of Texas MD Anderson Cancer Center

National Institutes of Health

National Heart Lung and Blood Institute

National Cancer Institute

Publisher

Elsevier BV

Reference31 articles.

1. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;N Engl J Med,2018

2. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

3. Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy;Wang;J Clin Oncol,2017

4. Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer;Hassanzadeh;J Thorac Dis,2020

5. Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study;Jing;Clin Transl Radiat Oncol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hadrontherapy in the context of cancer care in Italy;Health and Technology;2024-04-01